Presenilin-1 (PS1) and -2 (PS2), which when mutated cause familial Alzheimer disease, have been localized to numerous compartments of the cell, including the endoplasmic reticulum, Golgi, nuclear envelope, endosomes, lysosomes, the plasma membrane, and mitochondria. Using three complementary approaches, subcellular fractionation, ␥-secretase activity assays, and immunocytochemistry, we show that presenilins are highly enriched in a subcompartment of the endoplasmic reticulum that is associated with mitochondria and that forms a physical bridge between the two organelles, called endoplasmic reticulum-mitochondria-associated membranes. A localization of PS1 and PS2 in mitochondria-associated membranes may help reconcile the disparate hypotheses regarding the pathogenesis of Alzheimer disease and may explain many seemingly unrelated features of this devastating neurodegenerative disorder. Alzheimer disease (AD) is a late onset neurodegenerative disorder characterized by progressive neuronal loss, especially in the cortex and the hippocampus. 1 The two main histopathological hallmarks of AD are the accumulation of extracellular neuritic plaques, consisting predominantly of -amyloid (A), and of neurofibrillary tangles, consisting mainly of hyperphosphorylated forms of the microtubule-associated protein tau.
1The vast majority of AD is sporadic, but mutations in amyloid precursor protein (APP), presenilin-1 (PS1), and presenilin-2 (PS2) have been identified in the rarer familial form, which is similar to sporadic AD but has an earlier age of onset.PS1 and PS2 are aspartyl proteases that cleave their substrates within transmembrane regions. The active forms of PS1 and PS2 are N-and C-terminal fragments, which are produced by cleavage of full-length presenilin in its "loop" domain.2 PS1 and PS2 are components of the ␥-secretase complex that processes a number of plasma-membrane proteins, including Notch, Jagged, E-cadherin, and, most relevant to AD, APP. The ␥-secretase complex also contains three other structural subunits: APH1, nicastrin (also called APH2), and presenilin enhancer protein 2.2 Following cleavage of APP by -secretase, ␥-secretase cleaves the ϳ100-aa C-terminal "-stub" to release small amyloidogenic fragments, 40-and 42-aa in length (A40 and A42), that have been implicated in the pathogenesis of AD, as well as a ϳ60-aa APP intracellular domain.